COMMUNIQUÉS West-GlobeNewswire

Pharvaris Appoints David Nassif, J.D., as Chief Financial Officer
10/04/2024
ZUG, Switzerland, April 10, 2024 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to treat and prevent hereditary angioedema [...]
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, May 8, 2024
10/04/2024
SAN DIEGO, April 10, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its [...]
Terns Pharmaceuticals Appoints Melita Sun Jung as Chief Business Officer
10/04/2024
FOSTER CITY, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product [...]
Epic Bio to Participate in a Fireside Chat at the Canaccord Genuity Genetic Medicine for Generalists
10/04/2024
SOUTH SAN FRANCISCO, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- Epic Bio , a leading epigenetic editing company that plans to have its FSHD program enter the clinic this year, today announced that Amber Salzman, Ph.D., [...]
New Nextech Med Spa for Wellness and Weight Loss Software Increases Average Patient Encounter Revenue by 70%
10/04/2024
TAMPA, Fla., April 10, 2024 (GLOBE NEWSWIRE) -- Nextech, market leader of comprehensive technology solutions for specialty practices, has announced the launch of Nextech Med Spa for Wellness and Weight Loss with [...]
Oxurion Receives EUR 450,000 in the framework of the Atlas Funding Program : Eleventh tranche fully issued and paid-up
10/04/2024
Oxurion Receives EUR 450,000 in the framework of the Atlas Funding Program Eleventh tranche fully issued and paid-up Leuven, BELGIUM, 10 April 2024 – 07.00 PM CET – Oxurion NV (Euronext Brussels: OXUR), a [...]
Data Presented at AACR 2024 Showcase Precede Biosciences’ Power to Impact Precision Medicine from a Simple Blood Test
10/04/2024
Data further underscore potential to inform therapy selection for antibody drug conjugates and other target-directed therapies across breast, lung, and gastro-esophageal cancers Targets revealed from a single 1mL plasma [...]
Raydiant Oximetry Secures FDA Approval for Lumerah Investigational Device Exemption (IDE) Study
10/04/2024
SAN RAMON, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- Raydiant Oximetry, Inc. , a clinical-stage medical device company that develops medical technologies to improve outcomes for mothers and babies during childbirth, [...]
OSE Immunotherapeutics Receives €8.4 M in Public Funding to Support the Registration Phase 3 Clinical Trial of Cancer Vaccine Tedopi® in Lung Cancer
10/04/2024
OSE Immunotherapeutics Receives €8.4 M in Public Funding to Support the Registration Phase 3 Clinical Trial of Cancer Vaccine Tedopi® in Lung Cancer Nantes, France – April 10, 2024 – 6:00 pm CET – OSE Immunotherapeutics [...]
OSE Immunotherapeutics reçoit un financement public de 8,4 M€ pour soutenir l’essai clinique de Phase 3 d’enregistrement du vaccin Tedopi® contre le cancer du poumon
10/04/2024
OSE Immunotherapeutics reçoit un financement public de 8,4 M€ pour soutenir l’essai clinique de Phase 3 d’enregistrement du vaccin Tedopi® contre le cancer du poumon Nantes, France, le 10 avril 2024, 18 heures – OSE [...]
Aprea Therapeutics Announces Presentations on its Next Generation WEE1 Inhibitor, APR-1051, and A Novel Macrocyclic ATR Inhibitor, ATRN-119, at AACR Annual Meeting 2024
10/04/2024
Pre-clinical findings underscore the potential of APR-1051, a next-generation WEE1 kinase inhibitor, to be a well-tolerated and effective treatment for Cyclin E-overexpressing cancers IND for APR-1051 has been cleared; [...]
Ongoing Point of Care Ultrasound Certification Academy Study Aims to Identify Top 25 POCUS Practice Domains
10/04/2024
Study aims to help establish global curriculum and credentialing guidelines for clinicians and educators ROCKVILLE, Md., April 10, 2024 (GLOBE NEWSWIRE) -- Inteleos, a non-profit global healthcare certification [...]
University Cancer & Blood Center and University Health Alliance open High-Risk GI Clinic to address community needs
10/04/2024
State-of-the-art program features acclaimed physicians and experts in oncology and gastroenterology ATHENS, Ga., April 10, 2024 (GLOBE NEWSWIRE) -- University Cancer & Blood Center (UCBC), a leading oncology and [...]
EUROBIO SCIENTIFIC: RESULTAT ANNUEL 2023
10/04/2024
RESULTAT ANNUEL 2023 Croissance du cœur d’activité et déploiement stratégique Chiffre d’affaires Cœur d’activité 1 en croissance de 39% à 130 M€ les produits propriétaires atteignent 30% du CA la part du CA hors France [...]
EUROBIO SCIENTIFIC: 2023 ANNUAL RESULTS
10/04/2024
2023 ANNUAL RESULTS Growth in Core Business and strategic deployment Core business 1 revenues up 39% to €130m proprietary products account for 30% of revenues 38% of revenues generated outside France Resilient results [...]
FirstClass Healthcare Earns Perfect Score on NCCHC (National Commission on Correctional Health Care) Accreditation in the Gwinnett County Jail
10/04/2024
GWINNETT COUNTY, Ga., April 10, 2024 (GLOBE NEWSWIRE) -- FirstClass Healthcare , an Atlanta-based correctional and institutional healthcare organization, earned a perfect score from the National Commission on [...]
Major shareholder announcement – BlackRock, Inc.
10/04/2024
ANNOUNCEMENT NO. 260 Major shareholder announcement Major shareholder announcement – BlackRock, Inc. Pursuant to Section 30 of the Capital Markets Act, it is hereby announced that BlackRock, Inc. has informed ChemoMetec [...]
Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social
10/04/2024
Information relative au nombre total de droits de vote et d’actions composant le capital social Dijon, le 10 avril 2024 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui développe et [...]
Acryno To Blends AI and Luxury Concierge Services to Reimagine Healthcare
10/04/2024
The novel platform seeks to match patients with skilled medical experts to democratize access to quality providers and cut down on wait times for care NEW YORK, April 10, 2024 (GLOBE NEWSWIRE) -- In an era of rising [...]

Pages